Prophylaxis with Low Molecular Weight Heparin for Prevention of Placenta-related Recurrent Adverse Pregnancy Outcomes
Joel H. Kamda, Alessandro Ghidini, John C. Pezzullo & Sarah H. Poggi · International Blood Research & Reviews · 2014
Aims: To determine whether antenatal administration of low-molecular-weight-heparin (LMWH) reduces the recurrence of adverse pregnancy outcomes (APO). Study Design: Retrospective cohort study. Place and Duration of the Study: Inova Alexandria Hospital, Alexandria, VA and Georgeto...
Open access
Research Article
10.9734/IBRR/2014/9703